首页> 美国卫生研究院文献>Stem Cell Research Therapy >Stem cell-derived mitochondria transplantation: a novel strategy and the challenges for the treatment of tissue injury
【2h】

Stem cell-derived mitochondria transplantation: a novel strategy and the challenges for the treatment of tissue injury

机译:干细胞源性线粒体移植:一种新的策略和组织损伤治疗的挑战。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Damage of mitochondria in the initial period of tissue injury aggravates the severity of injury. Restoration of mitochondria dysfunction and mitochondrial-based therapeutics represent a potentially effective therapeutic strategy. Recently, mitochondrial transfer from stem cells has been demonstrated to play a significant role in rescuing injured tissues. The possible mechanisms of mitochondria released from stem cells, the pathways of mitochondria transfer between the donor stem cells and recipient cells, and the internalization of mitochondria into recipient cells are discussed. Moreover, a novel strategy for tissue injury based on the concept of stem cell-derived mitochondrial transplantation is pointed out, and the advantages and challenges are summarized.
机译:组织损伤初期线粒体的损​​伤加剧了损伤的严重性。线粒体功能障碍的恢复和基于线粒体的疗法代表了一种潜在的有效治疗策略。最近,已证明从干细胞转移线粒体在抢救受伤组织中起着重要作用。讨论了干细胞释放线粒体的可能机制,线粒体在供体干细胞和受体细胞之间转移的途径以及线粒体向受体细胞内化的作用。此外,指出了一种基于干细胞线粒体移植概念的组织损伤新策略,并总结了其优势和挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号